Heron Pharmaceutical Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 332

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 10

Heron Pharmaceutical General Information

Description

Developer and provider of pharmaceutical R&D services and specialty drug development solutions designed for the discovery and optimization of innovative, modified, and generic medicines. The company provides integrated preclinical development services-including API and formulation process development, quality and stability studies-as well as technology transfer and consulting, enabling biopharma clients to accelerate drug development and regulatory readiness.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Building 10, North District, Life Science and Technology Town
  • No. 568, Longmian Avenue, Jiangning District
  • Nanjing, Jiangsu 211100
  • China
+86 025
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Building 10, North District, Life Science and Technology Town
  • No. 568, Longmian Avenue, Jiangning District
  • Nanjing, Jiangsu 211100
  • China
+86 025

Heron Pharmaceutical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Heron Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Heron Pharmaceutical‘s full profile, request access.

Request a free trial

Heron Pharmaceutical Patents

Heron Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026214758-A1 Compound having synergistic analgesic effect, composition and use Pending 11-Apr-2025
WO-2023115511-A1 Arylpropionic acid derivative and emulsion preparation thereof Inactive 24-Dec-2021
EP-4134362-A1 Ibuprofen ester derivative and emulsion formulation thereof Active 29-Jun-2021
EP-4134362-A4 Ibuprofen ester derivative and emulsion formulation thereof Active 29-Jun-2021
EP-4134362-B1 Ibuprofen ester derivative and emulsion formulation thereof Active 29-Jun-2021 C07C69/96
To view Heron Pharmaceutical’s complete patent history, request access »

Heron Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Heron Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Heron Pharmaceutical‘s full profile, request access.

Request a free trial

Heron Pharmaceutical FAQs

  • When was Heron Pharmaceutical founded?

    Heron Pharmaceutical was founded in 2013.

  • Where is Heron Pharmaceutical headquartered?

    Heron Pharmaceutical is headquartered in Nanjing, China.

  • What is the size of Heron Pharmaceutical?

    Heron Pharmaceutical has 332 total employees.

  • What industry is Heron Pharmaceutical in?

    Heron Pharmaceutical’s primary industry is Drug Discovery.

  • Is Heron Pharmaceutical a private or public company?

    Heron Pharmaceutical is a Private company.

  • What is the current valuation of Heron Pharmaceutical?

    The current valuation of Heron Pharmaceutical is .

  • What is Heron Pharmaceutical’s current revenue?

    The current revenue for Heron Pharmaceutical is .

  • How much funding has Heron Pharmaceutical raised over time?

    Heron Pharmaceutical has raised $68.6M.

  • Who are Heron Pharmaceutical’s investors?

    Hubei Zhenghan Investment (Daye), Jiangsu Zhonggao Private Equity Fund Management, Qualifind Medical, Guosheng (Jiangsu) Venture Capital, and Xi'an Manareco are 5 of 8 investors who have invested in Heron Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process